95 related articles for article (PubMed ID: 6120179)
1. A new method for assessing the thyrotropin binding inhibitory activity in the immunoglobulins and whole serum of patients with Graves' disease.
Borges M; Ingbar JC; Endo K; Amir S; Uchimura H; Nagataki S; Ingbar SH
J Clin Endocrinol Metab; 1982 Mar; 54(3):552-8. PubMed ID: 6120179
[No Abstract] [Full Text] [Related]
2. Correlation between thyroid adenylate cyclase-stimulating and thyrotropin-binding inhibitor immunoglobulins in Graves' disease.
Chang TC; Chen FW; Chang CC; Liaw KY
Taiwan Yi Xue Hui Za Zhi; 1985 May; 84(5):579-85. PubMed ID: 2864384
[No Abstract] [Full Text] [Related]
3. Assays of thyroid-stimulating antibody.
McKenzie JM; Zakarija M
Methods Enzymol; 1985; 109():677-91. PubMed ID: 2859517
[No Abstract] [Full Text] [Related]
4. Evaluation of TBII activity in untreated Graves' disease using solubilised thyroid membranes.
Taylor JJ; Young ET; Holcombe M; Kendall-Taylor P
Ann Clin Biochem; 1985 Jul; 22 ( Pt 4)():366-70. PubMed ID: 2864013
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease.
O'Donnell J; Trokoudes K; Silverberg J; Row V; Volpé R
J Clin Endocrinol Metab; 1978 May; 46(5):770-7. PubMed ID: 233633
[TBL] [Abstract][Full Text] [Related]
6. Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay.
Vitti P; Valente WA; Ambesi-Impiombato FS; Fenzi GF; Pinchera A; Kohn LD
J Endocrinol Invest; 1982; 5(3):179-82. PubMed ID: 6286749
[TBL] [Abstract][Full Text] [Related]
7. A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol.
Kasagi K; Konishi J; Arai K; Misaki T; Iida Y; Endo K; Torizuka K
J Clin Endocrinol Metab; 1986 May; 62(5):855-62. PubMed ID: 2870075
[TBL] [Abstract][Full Text] [Related]
8. Serum protein inhibition of thyrotropin binding to human thyroid tissue.
Beall GN; Chopra IJ; Solomon DH; Kruger SR
J Clin Endocrinol Metab; 1978 Nov; 47(5):967-73. PubMed ID: 45474
[TBL] [Abstract][Full Text] [Related]
9. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
McKenzie JM; Zakarija M
J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449
[TBL] [Abstract][Full Text] [Related]
10. Adenosine 3',5'-monophosphate concentrations and responsiveness to thyrotropin and thyroid-stimulating immunoglobulins in normal and Graves' thyroids.
Kuzuya N; Uchimura H; Ikeda H; Chiu SC; Hamada N; Ito K; Nagataki S
J Clin Endocrinol Metab; 1980 Jul; 51(1):59-63. PubMed ID: 6247365
[No Abstract] [Full Text] [Related]
11. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD
J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
[TBL] [Abstract][Full Text] [Related]
12. Graves' immunoglobulin G stimulates iodide efflux in FRTL-5 thyroid cells.
Shoda Y; Kondo Y; Kobayashi I
J Clin Endocrinol Metab; 1993 Jul; 77(1):94-7. PubMed ID: 8100833
[TBL] [Abstract][Full Text] [Related]
13. Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor.
Vitti P; Elisei R; Tonacchera M; Chiovato L; Mancusi F; Rago T; Mammoli C; Ludgate M; Vassart G; Pinchera A
J Clin Endocrinol Metab; 1993 Feb; 76(2):499-503. PubMed ID: 8094393
[TBL] [Abstract][Full Text] [Related]
14. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay.
Vitti P; Rotella CM; Valente WA; Cohen J; Aloj SM; Laccetti P; Ambesi-Impiombato FS; Grollman EF; Pinchera A; Toccafondi R; Kohn LD
J Clin Endocrinol Metab; 1983 Oct; 57(4):782-91. PubMed ID: 6136523
[TBL] [Abstract][Full Text] [Related]
16. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins.
Bech K
Acta Endocrinol Suppl (Copenh); 1983; 254():3-38. PubMed ID: 6191508
[No Abstract] [Full Text] [Related]
17. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease.
Shinozawa T; Villadolid MC; Ingbar SH
J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173
[TBL] [Abstract][Full Text] [Related]
18. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
19. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
20. Thyroid stimulating immunoglobulins: measurement and clinical use.
Ollis CA; Tomlinson S; Munro DS
Clin Sci (Lond); 1985 Aug; 69(2):113-21. PubMed ID: 2866060
[No Abstract] [Full Text] [Related]
[Next] [New Search]
